Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MI › Farmington Hills › NPI 1336183367
Hospital

Botsford General Hospital

Botsford General Hospital was paid $72.21M by Medicaid between Jan 2018 and Dec 2024, across 509 billing codes. Its largest line is 99285, emergency room visit (most serious) — 27% of everything it billed.

33Billing provider infoBOTSFORD GENERAL HOSPITAL
FARMINGTON HILLS, MI 48336
33aNPI1336183367assigned 06/16/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$72.21M
24GClaims2,405,370
24DCodes billed509
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Michigan

Rank by total paid#16 of 86
Median peer was paid$21.55M
This provider vs. median3.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official COX, MATTHEW controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018217,388$8.57M
2019323,363$8.92M
2020295,577$8.49M
2021401,250$11.35M
2022398,499$11.79M
2023423,058$13.26M
2024incomplete346,235$9.84M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 27% 61,788 57,632 $19.35M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 9.5% 37,320 36,243 $6.86M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 8.1% 100,252 90,578 $5.88M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 5.2% 30,043 29,139 $3.72M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 4.6% 35,502 32,772 $3.31M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2.3% 16,971 11,314 $1.64M
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 2.0% 9,308 6,102 $1.48M
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.4% 12,659 12,449 $1.02M
96375 Therapeutic injection; each additional sequential IV push 1.4% 30,399 25,109 $982K
71046 Radiologic examination, chest; 2 views 1.2% 17,295 16,893 $872K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.2% 33,145 8,923 $831K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.1% 6,391 6,287 $824K
497 more codes
93975 1.0% 6,634 $745K
80061 Lipid panel <1% 49,538 $706K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 3,726 $679K
96361 Intravenous infusion, hydration; each additional hour <1% 19,242 $653K
59025 Fetal non-stress test <1% 7,200 $633K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 1,826 $614K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 1,134 $593K
G0378 Hospital observation service, per hour <1% 6,532 $593K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 31,609 $580K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 5,886 $578K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 31,372 $576K
J9271 Injection, pembrolizumab, 1 mg <1% 92 $567K
70450 Computed tomography, head or brain; without contrast material <1% 6,833 $524K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 9,777 $468K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 6,163 $461K
82947 <1% 19,033 $455K
76830 Ultrasound, transvaginal <1% 7,045 $420K
71045 Radiologic examination, chest; single view <1% 9,560 $399K
84443 Thyroid stimulating hormone (TSH) <1% 50,030 $377K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 25,510 $374K
77067 Screening mammography, bilateral, including computer-aided detection <1% 7,685 $370K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 7,534 $357K
J1745 Injection, infliximab, excludes biosimilar, 10 mg <1% 294 $341K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 23,934 $337K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 2,977 $301K
80053 Comprehensive metabolic panel <1% 66,238 $282K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 21,993 $275K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 31,609 $264K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 124,799 $262K
Q5103 Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg <1% 440 $250K
87480 <1% 21,791 $237K
87660 <1% 21,536 $233K
97162 <1% 4,069 $223K
87510 <1% 20,913 $222K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 10,077 $215K
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk <1% 520 $214K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 1,570 $212K
J2505 Injection, pegfilgrastim, 6 mg <1% 138 $209K
76801 <1% 3,312 $208K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 381 $208K
83036 Hemoglobin; glycosylated (A1C) <1% 44,100 $207K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 2,992 $203K
96415 <1% 4,217 $202K
97161 <1% 1,975 $194K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 9,329 $181K
71275 Computed tomographic angiography, chest, with contrast material <1% 2,269 $175K
94060 <1% 1,258 $171K
96367 <1% 4,980 $168K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 846 $167K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 16,616 $163K
93970 <1% 1,777 $162K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 1,815 $157K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 2,554 $147K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 326 $144K
93350 <1% 752 $143K
90651 <1% 1,012 $138K
93971 <1% 2,612 $132K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 4,257 $131K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 13,054 $128K
76770 <1% 1,998 $125K
96417 <1% 3,073 $120K
76642 <1% 3,168 $119K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 6,180 $118K
82607 <1% 16,984 $114K
80048 Basic metabolic panel (calcium, ionized) <1% 46,888 $112K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 2,590 $112K
90686 <1% 6,479 $111K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 7,459 $104K
86803 <1% 12,352 $101K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 6,174 $101K
77066 Tomosynthesis, mammo <1% 1,712 $100K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 447 $96K
86900 <1% 11,012 $94K
90750 <1% 620 $86K
10060 <1% 990 $82K
J1453 Injection, fosaprepitant, 1 mg <1% 2,399 $80K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 843 $80K
76536 <1% 1,532 $76K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 1,426 $70K
90732 <1% 868 $70K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 30,377 $68K
87086 Culture, bacterial; quantitative colony count, urine <1% 16,979 $66K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 2,308 $66K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 505 $65K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 179 $63K
86780 <1% 7,559 $62K
80074 <1% 2,696 $62K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 14,104 $60K
74022 <1% 3,071 $59K
82728 <1% 9,540 $59K
97165 <1% 1,410 $58K
90472 Immunization administration, each additional vaccine (list separately) <1% 4,255 $58K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 2,610 $57K
70491 <1% 564 $57K
84702 <1% 21,443 $57K
87340 <1% 10,712 $56K
70486 <1% 1,509 $56K
77065 Tomosynthesis, mammo <1% 1,289 $55K
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) <1% 4,241 $55K
90670 <1% 627 $52K
84466 <1% 8,758 $52K
36415 Collection of venous blood by venipuncture <1% 68,503 $51K
96411 <1% 1,427 $51K
84439 <1% 11,705 $51K
82746 <1% 7,248 $47K
90677 <1% 183 $42K
97166 <1% 1,019 $42K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 7,361 $41K
77063 Screening digital breast tomosynthesis, bilateral <1% 3,183 $41K
73630 <1% 4,208 $39K
74018 <1% 2,312 $39K
J0897 Injection, denosumab, 1 mg <1% 127 $38K
71250 <1% 690 $38K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 3,093 $38K
78815 Positron emission tomography (PET) for limited area imaging <1% 50 $36K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 1,497 $35K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 67 $35K
84481 <1% 3,989 $34K
73562 <1% 1,929 $34K
73130 <1% 3,096 $34K
74019 <1% 1,560 $34K
85027 <1% 15,770 $33K
86235 <1% 1,436 $33K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 533 $32K
96416 <1% 173 $32K
J2469 Injection, palonosetron hcl, 25 mcg <1% 2,956 $31K
83735 <1% 31,463 $31K
83540 <1% 9,792 $30K
58558 <1% 24 $30K
73610 <1% 3,043 $30K
71271 <1% 511 $29K
73030 <1% 2,569 $28K
87653 <1% 1,743 $28K
84403 <1% 1,923 $28K
87631 <1% 7,603 $27K
86592 <1% 9,832 $27K
86769 <1% 1,473 $26K
72125 Computed tomography, cervical spine; without contrast material <1% 2,422 $26K
87428 <1% 688 $25K
82670 <1% 1,592 $25K
93017 <1% 1,888 $25K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 2,052 $25K
84153 <1% 2,891 $25K
84460 <1% 10,243 $24K
84450 <1% 10,758 $24K
82565 <1% 10,181 $23K
83001 <1% 2,268 $23K
87186 <1% 4,976 $21K
86696 <1% 1,921 $21K
87077 <1% 4,732 $20K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 285 $19K
20610 <1% 143 $19K
73110 <1% 1,704 $19K
82043 <1% 6,670 $19K
88184 <1% 231 $19K
99406 <1% 1,255 $19K
80069 <1% 8,656 $18K
86038 <1% 3,266 $18K
83021 <1% 2,101 $18K
90746 <1% 268 $18K
87070 <1% 4,429 $18K
83002 <1% 1,759 $18K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 258 $17K
83970 <1% 829 $17K
J2506 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg <1% 37 $17K
96523 <1% 537 $17K
86762 <1% 2,404 $16K
84146 <1% 1,471 $16K
Q5107 Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg <1% 32 $15K
86160 <1% 1,613 $15K
97014 <1% 1,881 $15K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 255 $15K
72110 <1% 888 $15K
73502 <1% 1,315 $15K
82105 <1% 1,744 $14K
80051 <1% 4,649 $14K
86140 <1% 9,939 $14K
83880 <1% 3,742 $14K
86695 <1% 1,918 $14K
90739 <1% 107 $13K
86850 <1% 11,004 $13K
84520 <1% 6,933 $13K
86706 <1% 2,407 $13K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 4,473 $13K
86480 <1% 364 $12K
74183 <1% 64 $12K
84402 <1% 794 $11K
87147 <1% 2,721 $11K
81003 <1% 28,732 $11K
86225 <1% 1,872 $10K
64450 <1% 80 $10K
M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring <1% 57 $10K
88307 <1% 174 $10K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 78 $10K
Q0111 Wet mounts, including preparations of vaginal, cervical or skin specimens <1% 392 $10K
81514 <1% 56 $10K
81001 <1% 29,687 $10K
84550 <1% 4,889 $9K
84100 <1% 15,487 $9K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 420 $9K
90671 <1% 60 $9K
84478 <1% 714 $9K
86003 <1% 170 $9K
85652 <1% 8,226 $9K
82784 <1% 1,031 $9K
76377 <1% 1,124 $8K
85610 <1% 18,562 $8K
86200 <1% 1,540 $8K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 846 $8K
82570 <1% 3,938 $8K
82550 <1% 6,395 $8K
80076 <1% 6,271 $8K
73590 <1% 1,299 $8K
72170 <1% 1,250 $8K
93798 <1% 167 $8K
G0475 Hiv antigen/antibody, combination assay, screening <1% 599 $7K
82248 <1% 12,321 $7K
83690 <1% 16,944 $7K
10061 <1% 36 $7K
72141 <1% 50 $7K
72100 <1% 315 $7K
83013 <1% 214 $7K
91322 <1% 51 $7K
82950 <1% 2,757 $7K
J1750 Injection, iron dextran, 50 mg <1% 254 $7K
83655 <1% 1,022 $7K
82040 <1% 3,363 $7K
86787 <1% 1,015 $7K
82977 <1% 2,133 $7K
73564 <1% 1,240 $7K
82247 <1% 2,943 $7K
86431 <1% 2,378 $6K
87634 <1% 123 $6K
87529 <1% 242 $6K
90734 <1% 202 $6K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 1,307 $6K
81025 <1% 15,266 $6K
85730 <1% 15,398 $5K
70551 Magnetic resonance imaging, brain; without contrast material <1% 49 $5K
99495 <1% 82 $5K
G0008 Administration of influenza virus vaccine <1% 761 $5K
99385 <1% 74 $5K
80305 <1% 1,118 $5K
97116 <1% 633 $5K
82150 <1% 2,224 $5K
73090 <1% 793 $5K
88304 <1% 1,763 $5K
87632 <1% 65 $5K
83615 <1% 2,189 $5K
36430 <1% 29 $5K
82627 <1% 328 $4K
76870 <1% 269 $4K
90656 <1% 235 $4K
86704 <1% 651 $4K
87205 <1% 2,327 $4K
85046 <1% 1,927 $4K
86901 <1% 10,659 $4K
84075 <1% 1,547 $4K
88342 <1% 344 $4K
64415 <1% 79 $4K
82785 <1% 428 $4K
M0239 Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring <1% 34 $4K
83516 <1% 500 $4K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 13 $4K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 4,049 $3K
72131 <1% 75 $3K
86162 <1% 311 $3K
90480 <1% 68 $3K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 37 $3K
87536 <1% 53 $3K
73140 <1% 211 $2K
80050 General health panel <1% 464 $2K
72197 <1% 12 $2K
93880 <1% 26 $2K
84156 <1% 1,690 $2K
81002 <1% 1,521 $2K
82533 <1% 381 $2K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 33 $2K
99496 <1% 36 $2K
64400 <1% 15 $2K
93225 <1% 39 $2K
74178 <1% 12 $2K
87109 <1% 296 $2K
86039 <1% 363 $2K
87075 <1% 644 $2K
84155 <1% 1,124 $2K
84165 <1% 373 $2K
85379 <1% 5,260 $2K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 24 $2K
82652 <1% 111 $2K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 11,359 $2K
72040 <1% 221 $2K
93308 <1% 15 $2K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 2,809 $2K
99213 Doctor's office visit, returning patient (routine) <1% 52 $1K
76881 <1% 24 $1K
86376 <1% 192 $1K
94010 <1% 71 $1K
96376 <1% 6,318 $1K
84144 <1% 101 $1K
76942 <1% 2,162 $1K
77336 <1% 21 $1K
73070 <1% 103 $1K
87522 Neg quan hep c or qual rna <1% 57 $1K
84484 <1% 16,876 $1K
73080 <1% 176 $1K
76818 <1% 18 $1K
86360 <1% 43 $1K
G0297 Low dose ct scan (ldct) for lung cancer screening <1% 24 $1K
86580 <1% 200 $1K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision <1% 73 $999.81
96127 <1% 157 $987.49
97035 <1% 186 $981.05
99214 Doctor's office visit, returning patient (more involved) <1% 16 $976.24
88142 <1% 90 $971.96
87210 <1% 2,348 $893.72
86147 <1% 25 $855.17
86359 <1% 43 $826.67
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 558 $813.12
88143 <1% 71 $810.58
J1170 Injection, hydromorphone, up to 4 mg <1% 4,953 $800.00
73560 <1% 212 $772.64
82310 <1% 384 $770.65
70498 <1% 26 $750.85
11721 <1% 54 $735.17
86705 <1% 132 $722.53
C1729 Catheter, drainage <1% 271 $700.00
77080 <1% 12 $660.80
94726 <1% 1,040 $638.36
83550 <1% 235 $636.31
73060 <1% 176 $622.72
84238 <1% 46 $587.18
G0010 Administration of hepatitis b vaccine <1% 40 $581.66
86146 <1% 25 $580.22
87808 <1% 507 $519.89
97163 <1% 12 $505.82
90662 <1% 40 $504.38
89051 <1% 188 $491.70
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 31 $456.49
71101 <1% 134 $440.35
12001 <1% 713 $409.95
87040 <1% 2,066 $375.65
73120 <1% 18 $340.70
0003A <1% 13 $337.77
86923 <1% 68 $324.65
84134 <1% 71 $302.40
83605 <1% 10,411 $299.87
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 64 $297.11
82465 <1% 99 $288.15
82140 <1% 901 $285.81
85018 <1% 437 $267.84
84703 <1% 8,765 $252.84
97012 <1% 43 $231.80
96377 <1% 79 $228.90
86364 <1% 39 $196.82
72070 <1% 27 $195.15
70496 <1% 12 $191.52
82378 <1% 29 $190.05
86308 <1% 823 $181.74
84145 <1% 745 $173.44
94760 <1% 3,064 $166.50
97535 Self-care/home management training, each 15 minutes <1% 34 $156.64
82044 <1% 72 $154.82
G0009 Administration of pneumococcal vaccine <1% 13 $145.17
82805 <1% 1,907 $145.03
82962 <1% 3,213 $128.79
80164 <1% 57 $128.35
82677 <1% 13 $112.50
12011 <1% 182 $110.05
29125 <1% 83 $107.98
86765 <1% 15 $94.90
73552 <1% 111 $92.91
12002 <1% 177 $89.46
83014 <1% 17 $87.14
82010 <1% 2,000 $86.51
85045 <1% 36 $84.70
82077 <1% 428 $81.07
86336 <1% 13 $72.51
83993 <1% 12 $69.40
94618 <1% 13 $64.79
84132 <1% 193 $56.67
70360 <1% 12 $48.33
83930 <1% 299 $45.27
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 3,772 $38.33
90474 <1% 12 $36.00
98925 <1% 15 $31.88
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 34,806 $24.44
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 680 $23.68
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 19,051 $22.36
J2704 Injection, propofol, 10 mg <1% 13,141 $22.22
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 7,087 $21.26
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 14,794 $19.45
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 7,779 $18.22
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 24,564 $17.60
J3010 Injection, fentanyl citrate, 0.1 mg <1% 11,382 $14.27
J1790 Injection, droperidol, up to 5 mg <1% 902 $13.41
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 1,839 $12.07
85014 <1% 25 $11.82
J3480 Injection, potassium chloride, per 2 meq <1% 1,127 $10.62
80179 <1% 528 $10.20
80143 <1% 535 $10.20
J1644 Injection, heparin sodium, per 1000 units <1% 7,250 $7.04
88300 <1% 63 $6.39
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 3,314 $5.55
85384 <1% 92 $5.23
J1650 Injection, enoxaparin sodium, 10 mg <1% 1,810 $2.29
J0690 Injection, cefazolin sodium, 500 mg <1% 5,825 $1.91
J3475 Injection, magnesium sulfate, per 500 mg <1% 3,164 $1.68
J1920 Injection, labetalol hydrochloride, 5 mg <1% 14 $0.20
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 1,178 $0.02
90714 0% 2,149 $0.00
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 0% 124 $0.00
J1953 Injection, levetiracetam, 10 mg 0% 189 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 466 $0.00
J1580 Injection, garamycin, gentamicin, up to 80 mg 0% 198 $0.00
90715 0% 2,520 $0.00
94729 0% 1,034 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 0% 5,095 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 120 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 0% 214 $0.00
J0640 Injection, leucovorin calcium, per 50 mg 0% 568 $0.00
J2270 Injection, morphine sulfate, up to 10 mg 0% 4,414 $0.00
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose 0% 31 $0.00
C9113 Injection, pantoprazole sodium, per vial 0% 2,682 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 0% 1,792 $0.00
J1756 Injection, iron sucrose, 1 mg 0% 2,898 $0.00
J7120 Ringers lactate infusion, up to 1000 cc 0% 681 $0.00
J9190 Injection, fluorouracil, 500 mg 0% 1,228 $0.00
J2004 Injection, lidocaine hcl with epinephrine, 1 mg 0% 44 $0.00
90633 0% 51 $0.00
99173 0% 63 $0.00
A9577 Injection, gadobenate dimeglumine (multihance), per ml 0% 874 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 0% 979 $0.00
J2550 Injection, promethazine hcl, up to 50 mg 0% 50 $0.00
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 0% 182 $0.00
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 0% 459 $0.00
J7030 Infusion, normal saline solution , 1000 cc 0% 1,657 $0.00
58340 0% 17 $0.00
3078F 0% 46 $0.00
J3370 Injection, vancomycin hcl, 500 mg 0% 296 $0.00
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 0% 12 $0.00
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion 0% 16 $0.00
91300 0% 84 $0.00
90707 0% 12 $0.00
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm 0% 88 $0.00
J0736 Injection, clindamycin phosphate, 300 mg 0% 42 $0.00
Q0245 Injection, bamlanivimab and etesevimab, 2100 mg 0% 100 $0.00
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 0% 202 $0.00
G0390 Trauma response team associated with hospital critical care service 0% 12 $0.00
J2800 Injection, methocarbamol, up to 10 ml 0% 27 $0.00
76000 0% 14 $0.00
Q0239 Injection, bamlanivimab-xxxx, 700 mg 0% 34 $0.00
J2310 Injection, naloxone hydrochloride, per 1 mg 0% 19 $0.00
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 0% 2,483 $0.00
J2370 Injection, phenylephrine hcl, up to 1 ml 0% 2,486 $0.00
J1630 Injection, haloperidol, up to 5 mg 0% 6,614 $0.00
J2795 Injection, ropivacaine hydrochloride, 1 mg 0% 1,199 $0.00
J3360 Injection, diazepam, up to 5 mg 0% 1,496 $0.00
A9270 Non-covered item or service 0% 538 $0.00
96368 0% 960 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 0% 472 $0.00
J2060 Injection, lorazepam, 2 mg 0% 4,434 $0.00
97010 0% 6,131 $0.00
J2360 Injection, orphenadrine citrate, up to 60 mg 0% 75 $0.00
A9585 Injection, gadobutrol, 0.1 ml 0% 717 $0.00
J3411 Injection, thiamine hcl, 100 mg 0% 353 $0.00
64488 0% 160 $0.00
36416 0% 59 $0.00
J0360 Injection, hydralazine hcl, up to 20 mg 0% 561 $0.00
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg 0% 340 $0.00
94761 0% 500 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 0% 335 $0.00
J7050 Infusion, normal saline solution, 250 cc 0% 1,571 $0.00
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 0% 1,011 $0.00
90632 0% 162 $0.00
J9045 Injection, carboplatin, 50 mg 0% 266 $0.00
3074F 0% 120 $0.00
J1030 Injection, methylprednisolone acetate, 40 mg 0% 28 $0.00
91305 0% 45 $0.00
A9573 Injection, gadopiclenol, 1 ml 0% 223 $0.00
J1836 Injection, metronidazole, 10 mg 0% 130 $0.00
J7999 Compounded drug, not otherwise classified 0% 229 $0.00
A4648 Tissue marker, implantable, any type, each 0% 25 $0.00
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care 0% 1,006 $0.00
J7060 5% dextrose/water (500 ml = 1 unit) 0% 347 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 377 $0.00
J3490 Unclassified drugs 0% 549 $0.00
84270 0% 26 $0.00
J9267 Injection, paclitaxel, 1 mg 0% 38 $0.00
90680 0% 37 $0.00
90698 0% 38 $0.00
C1769 Guide wire 0% 127 $0.00
C1781 Mesh (implantable) 0% 12 $0.00
J1940 Injection, furosemide, up to 20 mg 0% 15 $0.00
J1010 Injection, methylprednisolone acetate, 1 mg 0% 13 $0.00
80320 0% 18 $0.00
J3410 Injection, hydroxyzine hcl, up to 25 mg 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCOX, MATTHEW (CHIEF FINANCIAL OFFICER)
Same official

Other billing entities under COX, MATTHEW

Full network →
ProviderLocationPaid
Spectrum Health HospitalsGrand Rapids, MI$243.22M
Oakwood Healthcare, INC.Dearborn, MI$165.61M
William Beaumont HospitalRoyal Oak, MI$162.64M
William Beaumont HospitalTroy, MI$84.88M
Lakeland Hospitals at Niles and ST Joseph, INCSaint Joseph, MI$78.22M
William Beaumont HospitalGrosse Pointe, MI$61.49M
Oakwood Healthcare, INC.Wayne, MI$55.44M
Oakwood Healthcare, INC.Taylor, MI$50.28M
Oakwood Healthcare, INC.Trenton, MI$23.26M
Spectrum Health UnitedGreenville, MI$20.99M
Mecosta County Medical CenterBig Rapids, MI$19.50M
Pennock HospitalHastings, MI$15.24M
Reed City Hospital CorporationReed City, MI$15.02M
Zeeland Community HospitalZeeland, MI$10.12M
Lakeland Community Hospital WatervlietWatervliet, MI$9.85M
Lakeland Community Hospital WatervlietNiles, MI$9.05M
Visiting Nurse Services of Western MichiganGrand Rapids, MI$4.54M
Lakeland Hospitals at Niles and ST Joseph, INCBenton Harbor, MI$3.33M
Banner Mesa Surgery Center LLCMesa, AZ$2.80M
Lakeland Community Hospital WatervlietWatervliet, MI$2.55M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.